CSI/PH Substance Use Treatment Services

Tender description

CSI/PH Substance Use Treatment Services This service includes a range of inpatient and community substance use early engagement, treatment, and support services and a targeted youth service. Discontinuation of the procurement process: Bristol City Council is discontinuing the above named procurement process. We strongly encourage all providers to submit or resubmit a bid for this opportunity when it is re-let. If you have further questions regarding this notice please use the message function on the ProContract system for the discontinued opportunity. Lot 1: CSI/PH Substance Use Treatment Services Local Authorities are responsible for commissioning substance use treatment services as part of their public health responsibilities. Bristol City Council (BCC) commissions a range of inpatient and community substance use early engagement, treatment, and support services, currently provided by Recovery Orientated Alcohol and Drugs Service (ROADS), and a targeted youth service. Our current services have been in place since 2018 and will be replaced by newly commissioned services in 2025. Our vision is to recommission a specialist alcohol and other drug early intervention, treatment and recovery system for children, young people, and adults which is person centred, preventative, inclusive, innovative, and aspirational. Following public consultation we are now commissioning a single strategic partner provider, or a single lead provider of a consortia approach. This is to provide clear leadership and accountability that promotes effective collaboration different elements of the service. The provider will ensure an easily recognisable, and navigable treatment system. The strategic partner will need to demonstrate they understand the diversity of the Bristol population and provide inclusion in service delivery with a workforce that is representative of the Bristol population, as well as a person-centred and holistic approach that is evidenced based, and trauma informed.